Eton Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.72 billion, with shareholders equity totaling $86.92 million.
The company employs approximately 16 people and operates in the Health sector, within the Pharmaceutical Products industry.
Over the past 12 months, Eton Pharmaceuticals Inc. reported $141.06 million in revenue, generating net income of $49.86 million.
Key financial metrics include a P/E ratio of 34.44, a price-to-book (P/B) ratio of 19.75, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ETON.